Drug Shortage Report for M-LEVETIRACETAM
Report ID | 225536 |
Drug Identification Number | 02524589 |
Brand name | M-LEVETIRACETAM |
Common or Proper name | M-LEVETIRACETAM |
Company Name | MANTRA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LEVETIRACETAM |
Strength(s) | 750MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 120 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2024-02-19 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1000 RUE DU LUX SUITE 201 BROSSARD, QUEBEC CANADA J4Y 0E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-10-01 | French | Compare |
v5 | 2024-10-01 | English | Compare |
v4 | 2024-09-03 | French | Compare |
v3 | 2024-09-03 | English | Compare |
v2 | 2024-04-18 | French | Compare |
v1 | 2024-04-18 | English | Compare |
Showing 1 to 6 of 6